MODULATION OF FUNCTIONAL MACROPHAGE ACTIVITY BY HLDF6 PEPTIDE UPON ADDING OPIATE RECEPTOR AGONISTS
https://doi.org/10.15789/1563-0625-2005-1-77-84
Abstract
Abstract.The effect of a hexamer fragment of the peptide differentiation factor of the HL–60 cell line, HLDF6, on functional activity of C57Bl/6 mouse macrophages upon adding selective agonists of μ–, δ– and κ–type opiate receptors (DAGO, DADLE and Dynorphin (1–13) has been studied in the cell culture. It has been shown that opiate agonists were capable of enhancing adhesive properties and functional activity of macrophages during their direct interaction with cells. The intensity of stimulation depended on the type of the agonist and, respectively, the type of the opiate receptor. HLDF6 peptide enhanced macrophage activity after addition to the culture medium both at the initial cultivation stage and at the moment of phagosytosis induction. The data concerning the combined administration of HLDF6 and opiate agonists suggest the interaction between the peptide and the endogenous opiate system. (Med. Immunol., 2005, vol.7, № 1, pp 77584)
About the Authors
E. D. Danilenko
Научно–исследовательский конструкторско–технологический институт биологически активных веществ ГНЦ вирусологии и биотехнологии «Вектор», г. Бердск Новосибирской области
Russian Federation
Russian Federation
V. A. Fadina
Научно–исследовательский конструкторско–технологический институт биологически активных веществ ГНЦ вирусологии и биотехнологии «Вектор», г. Бердск Новосибирской области
Russian Federation
Russian Federation
V. I. Мasycheva
Научно–исследовательский конструкторско–технологический институт биологически активных веществ ГНЦ вирусологии и биотехнологии «Вектор», г. Бердск Новосибирской области
Russian Federation
Russian Federation
V. V. Samukov
НИИ молекулярной биологии ГНЦ вирусологии и биотехнологии «Вектор», пгт. Кольцово Новосибирской области
Russian Federation
Russian Federation
I. A. Коstanyan
Институт биоорганической химии им. М.М.Шемякина и Ю.А.Овчинникова РАН, г. Москва
Russian Federation
Russian Federation
References
1. Жохов С.С., Костанян И.А., Гибанова Н.В. Сурина Е.А., Сторожева З.И., Бабиченко И.И. Липкин В.М. Сходство и различие действия пептидов TGENHR и TQVEHR на промиелоциты линии HL–60 и клетки Пуркинье червя мозжечка крыc//Доклады академии наук. — 2004. — Т.394, N5. – С. 696–669.
2. Костанян И.А., Астапова М.В., Новолотская Е.В., Лепихова Т.Н., Драницына С.М., Телегин Г.В. Родионов И.Л., Байдакова Л.К., Золотарев Ю.А., Молотковская И.М., Липкин В.М. Биологически активный фрагмент фактора дифференцировки клеток линии HL–60. Идентификация и свойства // Биоорганическая хим. — 2000. — Т.26, № 7. — С.505–511.
3. Литвинова С.В., Костанян И.А., Аристова В.В. Колюжный А.Л., Шульговский В.В., Теребилина Н.Н., Панченко Л.Ф. Использование пептида HLDF–6 для коррекции нарушений эндогенной опиатной системы потомков морфинзависимых животных //Бюл. эксп. биол. мед. — 2003. — Т.135, N2. — С.133–135.
4. Симбирцев А.С., Пигарева Н.В., Конусова В.Г. // Вестник Рос.Акад.мед.наук. — 1993. — №2. — С.18–22.
5. Bidlack J.M. Detection and function of opioid receptors on cells from the immune system //Clin. Diagnostic Lab.Immunol. — 2000. — Vol.7, N5. — P.719–723.
6. Casselas A.M., Guardiola H., Renaud F.L. Inhibition by opioids of phagocytosis in peritoneal macrophages // Neuropeptides. — 1991. — Vol.18, N1. — P.35–40.
7. Foris G., Medgyesi G.A., Gyimesi E., Hauck M. Met–enkephalin induced alterations of macrophage functions // Mol.Immunol. — 1984. — Vol.21,N8. — P.747–750.
8. Foris G., Medgyesi G.A., Nagy J.T., Varga Z. Concentration–dependent effect of met–enkephalin on human polymorphonuclear leukocytes // Ann. N. Y. Acad. Sci. — 1987. — Vol.496. — P.151–157.
9. Gamaley S.G., Fedosova L.К., Danilenko Е.D. Masycheva V.I., Kostanyan I.А. The study of the interaction of the HLDF6 peptide differentiation factor fragment with the opioid receptor system // Intern. interdisciplinary workshop “New technologies in medicine and ecology, integrative medicine” Vysokie Tatry, Slovakia, 13 25 January, 2003. — P.30–32.
10. Gottlieb P., Beretz A., Fridkin M. Tuftsin analogs for probing its specific receptor site on phagocytic cells // Eur.J.Biochem. — 1982. — Vol. 125. — P. 631–638.
11. Heagy W., Laurance M., Cohen E., Finberg R. Neurohormones regulate T cell function // J. Exp. Med. — 1990. — Vol.171, N5. — P.1625 1633.
12. House R.V., Thomas P.T., Bhargava H.N. A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides // Peptides. — 1996. — Vol.17, N1. — P.75–81.
13. Ichinose M., Assai M., Sawada M. Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages // J.Neuroimmunol. — 1995. — Vol.60. — P.37–43.
14. Keith D.E., Anton B., Murray S.R., Zaki P.A. Chu P.C., Lissin D.V., Monteillet–Agius G., Stewart P.L., Evans C.J., Von Zastrow M. Mu–opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain // Mol. Pharmacol. — 1998. — Vol. 53. — P.377–378.
15. Law P.–Y., Loh H.H. Regulation of opioid receptor activities // J. Pharmacol Exp. Ther. — 1999. — Vol. 289, N2. — P.607–624.
16. Lazaro M.I., Tomassini N., Gonzalez I., Renaud F.L. Reversibility of morphine effects on phagocytosis by murine macrophages // Drug Alcohol. Depend. — 2000. — Vol.8, N1 2. — P.159–164.
17. Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB. Morphine–induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide // J.Immunol. — 1996. — Vol.156. — P.4845–4850.
18. Masycheva V.I., Fedosova L.K., Danilenko E.D. Kostanyan I.A., Samukov V.V. HLDF6 peptide correcton of dynorphin amnesic effects // Intern. Narcotics Res. Conf. (34th, Perpignan, France, July 6–11, 2003): Programme&abstr. N.P., 2003. — P.80.
19. Peterson P., Gekker G., Brummitt C., Pentel P. Bullock M., Simpson M., Hitt J., Sharp B. Suppression of human peripheral blood mononuclear cell function by methadone and morphine // J. Infect. Dis. — 1989. — Vol.159 — P.480–487.
20. Petty H.R., Martin S.M. Combinative ligand–receptor interactions: effects of cAMP, epinephrine, and met–enkephalin on RAW264 macrophage morphology spreading, adherence, and microfilaments // J.Cell Physiol. — 1989. — Vol.138, N2. — P.247–256.
21. Rook G.A.W., Steel J., Umar S., Dockrell H.M. A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma–interferon // J. Immunol. Meth. – 1985. — Vol.82, №1. — P.161–167.
22. Rouveix B. Opiates and immune function. Consequences on infectious diseases with special reference to AIDS // Therapie. — 1992. — Vol.47,N6. — P.503–512.
23. Roy S., Loh H.H. Effects of opioids on the immune system // Neurochem.Res. — 1996. — Vol.21. — P.1306— 1375.
24. Sabirov A.N., Kim Y. –D., Kim H.–J., Samukov V.V. Fmoc – and Nsc–groups as a base labile N(a)–amino protection: a comparative study in the automated SPPS // Protein Pept. Lett. — 1998. — Vol. 5, N 2. — P. 307–312.
25. Sowa G., Gekker G., Lipovsky M.M., Hu S. Chao C.C., Molitor T.W., Peterson P.K. Inhibition of swine microglial cell phagocytosis of Cryptococcus neoformans by femtomolar concentrations of morphine // Biochem.Pharmacol. — 1998. — Vol.53. — P.823–828.
26. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K. Jr., Magazine H.I., Bilfinger T.V., Hartman A.R. Fricchione GL., Liu Y., Makman M.H..Opioid and opiate immunoregulatory processes // Crit.Rev.Immunol. — 1996. — Vol.16. — P.109–144.
27. Szabo I., Rojavin M., Bussiere J.L., Eisenstein T.K. Adler M.W., Rogers T.J. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids // J.Pharmacol.Exp.Ther. — 1993. — Vol.267, N2. — P.703–706.
28. Tomassini N., Renaud F., Roy S., Loh H.H. Morphine inhibits Fc–mediated phagocytosis through mu and delta opioid receptors // J. Neuroimmunol. — 2004. — Vol.147. — P.131–133.
29. Tosk J.M., Grim J.R., Kinback K.M., Sale E.J. Bozzetti L.P., Will A.D. Modulation of chemiluminescence in a murine macrophage cell line by neuroendocrine hormones // Int. J. Immunopharmacol. — 1993. — Vol.15, N5. — P.615–620.
30. Trapaidze N., Keith D.E., Cvejic S., Evans C.J. Devi L.A. Sequestration of the delta opioid receptor. Role of the C terminus in agonist–mediated internalization// J. Biol. Chem. — 1996. — Vol.271. — P.29279–29285.
31. Wang H., Lin J., Liu J. Regulation of antiSRBC antibody production by opioids and their mechanisms // Chin. Med. Sci. J. — 1995. — Vol.10, N3. — P.125–130.
Review
For citations:
Danilenko E.D., Fadina V.A., Мasycheva V.I., Samukov V.V., Коstanyan I.A. MODULATION OF FUNCTIONAL MACROPHAGE ACTIVITY BY HLDF6 PEPTIDE UPON ADDING OPIATE RECEPTOR AGONISTS. Medical Immunology (Russia). 2005;7(1):77-84. (In Russ.) https://doi.org/10.15789/1563-0625-2005-1-77-84
Views:
1153
Email this article 